CN101991726A - Medicine composite for treating cytomegalovirus and preparation method thereof - Google Patents
Medicine composite for treating cytomegalovirus and preparation method thereof Download PDFInfo
- Publication number
- CN101991726A CN101991726A CN200910013401XA CN200910013401A CN101991726A CN 101991726 A CN101991726 A CN 101991726A CN 200910013401X A CN200910013401X A CN 200910013401XA CN 200910013401 A CN200910013401 A CN 200910013401A CN 101991726 A CN101991726 A CN 101991726A
- Authority
- CN
- China
- Prior art keywords
- channel
- parts
- cold
- spleen
- taste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine composite for treating cytomegalovirus, which comprises the following components in parts by weight: 62-95 parts of radix isatidis, 38-57 parts of honeysuckle, 5-20 parts of salvia miltiorrhiza, 16-35 parts of rhizoma atractylodis, 3-7 parts of alisma orientale and 22-43 parts of rhubarb. The taste of the radix isatidis is bitter and cold, and the radix isatidis enters the hepatic blood points and stomach blood points and is used for clearing away heat and toxic material and cooling blood; the taste of the honeysuckle is sweet and cold, the honeysuckle enters the lung channel and the stomach channel and is used for clearing away heat and toxic material; the taste of the rhizoma atractylodis is bitter and mild, the rhizoma atractylodis enters the spleen channel and the stomach channel and is used for invigorating the spleen, eliminating dampness, dispelling melancholy and avoiding dirty; the taste of the alisma orientale is sweet and cold, and the alisma orientale enters the kidney channel and the urinary bladder channel; and the taste of the rhubarb is bitter and cold, and the rhubarb enters the stomach channel, the spleen channel, the intestine channel, the liver channel and the pericardium channel. The medicine composite has the efficacy of purgating heat and bowels and is used for treating gastrointestinal real hot stagnancy, constipation, abdominal swelling, unpalpable abdominal pain, even high fever, coma and delirium like large chengqi decoction, or cold settling constipation due to Spleen Yang deficiency like spleen warming soup. The medicine has the characteristics of short treatment period, quick response, small side effect and the like.
Description
Technical field
The present invention relates to a kind of Chinese medicine, especially relate to a kind of pharmaceutical composition for the treatment of cytomegalovirus and preparation method thereof.
Background technology
Cytomegalovirus infection is a kind of systemic infection disease that is caused by cytomegalovirus, but fetus was given in vertical transmission after the anemia of pregnant woman was ill, cause intrauterine infection, make fetus serious symptoms and sign occur, even cause the low and birth backsight of habitual abortion, premature labor, stillborn fetus, congenital malformation, neonatal death, mongolism, small for date infant, cerebral palsy, neonatal jaundice, infant intelligence to listen sequela at a specified future date such as ability and intellectual development fall behind.Western medicine does not still have effective, safe especially anti-CMV medicine at present to cmv infection.
Summary of the invention
The technical problem to be solved in the present invention provides a kind of pharmaceutical composition for the treatment of cytomegalovirus and preparation method thereof.Characteristics such as this drug regimen has short treating period, instant effect on the disease of treatment cytomegalovirus, side effect is little.
In order to solve the problem that prior art exists, the technical solution used in the present invention is:
A kind of pharmaceutical composition for the treatment of cytomegalovirus, form according to the following number of weight ratio by following component:
Radix Isatidis: Flos Lonicerae: Radix Salviae Miltiorrhizae: Rhizoma Atractylodis: Rhizoma Alismatis: Radix Et Rhizoma Rhei=62-95: 38-57: 5-20: 16-35: 3-7: 22-43.
Described a kind of pharmaceutical composition for the treatment of cytomegalovirus, form according to the following number of weight ratio by following component:
Radix Isatidis: Flos Lonicerae: Radix Salviae Miltiorrhizae: Rhizoma Atractylodis: Rhizoma Alismatis: Radix Et Rhizoma Rhei=81: 45: 16: 22: 5: 38.
Prepare described a kind of method for the treatment of the pharmaceutical composition of cytomegalovirus, may further comprise the steps:
After getting the above-mentioned medicine pulverize of respectively distinguishing the flavor of in described ratio, fully mix homogeneously gets final product.
Advantage and effect that the present invention had are:
Radix Isatidis nature and flavor hardship, cold.Go into liver, stomach blood system.Heat clearing away, detoxifcation, removing heat from blood.Control influenza, epidemic encephalitis, encephalitis b, pneumonia, erysipelas, pyretic toxicity is sent out speckle, and coma is told nosebleed, pharyngeal swelling, mumps, acute catarrhal conjunctivitis, the skin ulcer rash, crimson tongue is purple dark, sore throat, scarlet fever, major part pestilence, carbuncle; Can prevent and treat epidemic encephalitis type B, acute, chronic hepatitis, mumps, osteomyelitis.The Flos Lonicerae nature and flavor are sweet, and are cold.Go into lung, stomach warp.Heat clearing away, detoxifcation.Control the epidemic febrile disease heating, toxic-heat and blood stasis, carbuncle and ulcer, toxic swelling, scrofula, anal fistula.Radix Salviae Miltiorrhizae is gone into the heart, Liver Channel.Blood circulation promoting and blood stasis dispelling, calming heart and tranquilizing mind, evacuation of pus, pain relieving.Control angina pectoris, menoxenia, dysmenorrhea, amenorrhea, metrorrhagia leukorrhagia ， mass in the abdomen gathers, abdominal pain due to blood stasis, arthralgia, palpitation with fear sleeplessness, malignant boil toxic swelling.The Rhizoma Atractylodis nature and flavor are arduous, temperature.Go into spleen, stomach warp.Spleen invigorating, dampness, resolving depression is warded off dirty.Control wet the Sheng and be stranded spleen, the asthenia drowsiness, gastral cavity painful abdominal mass abdominal distention, inappetence, vomiting is had loose bowels.The Rhizoma Alismatis nature and flavor are sweet, and are cold.Go into kidney, urinary bladder channel.Diuretic, eliminating dampness by diuresis expels the heat-evil.Control dysuria, edema distension, vomiting, dysentery, phlegm retention, beriberi, gonorrhea, hematuria.The Radix Et Rhizoma Rhei bitter in the mouth, cold in nature.Return stomach, spleen, large intestine, liver, pericardium channel.Have the purging heat to relax the bowels effect, be used for that the gastrointestinal excess-heat is stagnant, constipation, abdominal part distension, pain with tenderness, even hyperpyrexia, unconsciousness and delirium, as DACHENGQI TANG; Or the cold accumulation and constipation of spleen YANG deficiency, as wenpi decoction.Courses of pharmaceuticals of the present invention is short, instant effect, and side effect is little.
The specific embodiment
Embodiment 1:
A kind of pharmaceutical composition for the treatment of cytomegalovirus, form according to the following number of weight ratio by following component:
Radix Isatidis: Flos Lonicerae: Radix Salviae Miltiorrhizae: Rhizoma Atractylodis: Rhizoma Alismatis: Radix Et Rhizoma Rhei=95: 38: 5: 16: 3: 22.
Prepare described a kind of method for the treatment of the pharmaceutical composition of cytomegalovirus, be may further comprise the steps:
After getting the above-mentioned medicine pulverize of respectively distinguishing the flavor of in described ratio, fully mix homogeneously gets final product.
Embodiment 2:
A kind of pharmaceutical composition for the treatment of cytomegalovirus, form according to the following number of weight ratio by following component:
Radix Isatidis: Flos Lonicerae: Radix Salviae Miltiorrhizae: Rhizoma Atractylodis: Rhizoma Alismatis: Radix Et Rhizoma Rhei=62: 57: 20: 35: 7: 43.
Its preparation method is with embodiment 1.
Embodiment 3:
Described a kind of pharmaceutical composition for the treatment of cytomegalovirus, form according to the following number of weight ratio by following component:
Radix Isatidis: Flos Lonicerae: Radix Salviae Miltiorrhizae: Rhizoma Atractylodis: Rhizoma Alismatis: Radix Et Rhizoma Rhei=81: 45: 16: 22: 5: 38.
Its preparation method is with embodiment 1.
Embodiment 4:
A kind of pharmaceutical composition for the treatment of cytomegalovirus, form according to the following number of weight ratio by following component:
Radix Isatidis: Flos Lonicerae: Radix Salviae Miltiorrhizae: Rhizoma Atractylodis: Rhizoma Alismatis: Radix Et Rhizoma Rhei=71: 44: 18: 31: 6: 30.
Its preparation method is with embodiment 1.
Embodiment 5:
A kind of pharmaceutical composition for the treatment of cytomegalovirus, form according to the following number of weight ratio by following component:
Radix Isatidis: Flos Lonicerae: Radix Salviae Miltiorrhizae: Rhizoma Atractylodis: Rhizoma Alismatis: Radix Et Rhizoma Rhei=90: 52: 15: 26: 4: 39.
Its preparation method is with embodiment 1.
Claims (3)
1. pharmaceutical composition for the treatment of cytomegalovirus is characterized in that being made up of according to the following number of weight ratio following component:
Radix Isatidis: Flos Lonicerae: Radix Salviae Miltiorrhizae: Rhizoma Atractylodis: Rhizoma Alismatis: Radix Et Rhizoma Rhei=62-95: 38-57: 5-20: 16-35: 3-7: 22-43.
2. a kind of pharmaceutical composition for the treatment of cytomegalovirus according to claim 1 is characterized in that being made up of according to the following number of weight ratio following component:
Radix Isatidis: Flos Lonicerae: Radix Salviae Miltiorrhizae: Rhizoma Atractylodis: Rhizoma Alismatis: Radix Et Rhizoma Rhei=81: 45: 16: 22: 5: 38.
3. prepare the described a kind of pharmaceutical composition for the treatment of cytomegalovirus of claim 1, it is characterized in that may further comprise the steps:
After getting the above-mentioned medicine pulverize of respectively distinguishing the flavor of in described ratio, fully mix homogeneously gets final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910013401XA CN101991726A (en) | 2009-08-25 | 2009-08-25 | Medicine composite for treating cytomegalovirus and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910013401XA CN101991726A (en) | 2009-08-25 | 2009-08-25 | Medicine composite for treating cytomegalovirus and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101991726A true CN101991726A (en) | 2011-03-30 |
Family
ID=43782802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910013401XA Pending CN101991726A (en) | 2009-08-25 | 2009-08-25 | Medicine composite for treating cytomegalovirus and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101991726A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10195242B2 (en) * | 2013-01-25 | 2019-02-05 | Wintermute Biomedical, Inc. | Therapeutic compounds |
| US11065220B2 (en) | 2017-02-13 | 2021-07-20 | Wintermute Biomedical, Inc. | Anti-pathogenic therapeutic compositions |
| US11103475B2 (en) | 2018-10-01 | 2021-08-31 | Wintermute Biomedical, Inc. | Therapeutic compositions of undecylenic acid and arginine |
-
2009
- 2009-08-25 CN CN200910013401XA patent/CN101991726A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10195242B2 (en) * | 2013-01-25 | 2019-02-05 | Wintermute Biomedical, Inc. | Therapeutic compounds |
| US11065220B2 (en) | 2017-02-13 | 2021-07-20 | Wintermute Biomedical, Inc. | Anti-pathogenic therapeutic compositions |
| US11103475B2 (en) | 2018-10-01 | 2021-08-31 | Wintermute Biomedical, Inc. | Therapeutic compositions of undecylenic acid and arginine |
| US11154524B2 (en) | 2018-10-01 | 2021-10-26 | Wintermute Biomedical, Inc. | Therapeutic compositions of decanoic acid and arginine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103393821A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation and preparation method thereof | |
| CN104324338A (en) | Nursing patch for bedsore | |
| CN102018836B (en) | Chinese traditional medicine for treating mixed hemorrhoids | |
| CN103263647B (en) | Traditional Chinese medicine for treating postnatal lochiorrhea and preparation method thereof | |
| CN101991726A (en) | Medicine composite for treating cytomegalovirus and preparation method thereof | |
| CN102895582A (en) | Medicine treating stomach diseases | |
| CN104147200B (en) | Traditional Chinese medicinal composition for treating gynecologic inflammation and preparation method thereof | |
| CN103751691B (en) | A kind of medicine for the treatment of eczema | |
| CN104435326A (en) | Traditional Chinese medicine preparation for treating acute mastitis | |
| CN103919874A (en) | Traditional Chinese medicine powder for treating dental ulcer | |
| CN115282229B (en) | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type coronary heart disease and preparation method thereof | |
| CN103041328A (en) | Traditional Chinese medicine composition for treating blood stasis type lochiorrhea | |
| CN105250878A (en) | Traditional Chinese medicine for treating sub-acute infective endocarditis | |
| CN104707046A (en) | Traditional Chinese medicine for treating pelvic inflammation | |
| CN101664517B (en) | Traditional Chinese medicine for treating encephalitis | |
| CN103656381A (en) | Externally-used lotion for treating hemorrhoids | |
| CN105477201A (en) | Traditional Chinese medicine preparation for treating influenza and preparation method of traditional Chinese medicine preparation for treating influenza | |
| CN105796949A (en) | Decoction medicine for treating ulcer and preparation method thereof | |
| CN104324114A (en) | Traditional Chinese medicine preparation for treating dysentery | |
| CN104587254A (en) | Capsule for treating wind-heat type common cold and preparation method of capsule | |
| CN104324185A (en) | Traditional Chinese medicine composition for treating leukorrhagia and preparation method thereof | |
| CN106729436A (en) | Detoxicating stagnation resolvation tonifying liver soup | |
| CN103386104B (en) | Traditional Chinese medicine composite for curing erysipelas and preparation method thereof | |
| CN104096033A (en) | Chinese medicinal preparation for treating diarrhea | |
| CN117224646A (en) | Traditional Chinese medicine formula for treating cholestatic liver diseases, traditional Chinese medicine product and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110330 |